|
• |
|
|
|
HD Biosciences Co., Ltd. (HDB), a leading biology-focused preclinical drug discovery contract research organization (CRO), today announces its merge with WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform. |
|
• |
|
|
|
HD Biosciences Co., Ltd. (HDB), a leading biology-focused preclinical drug discovery contract research organization (CRO), and Luxcel Biosciences Ltd (Luxcel), a Cork based biotechnology company, announced today that they have entered a strategic partnership to co-market and provide new assay technologies for preclinical drug safety services. |
|
• | |
|
|
HD Biosciences Co., Ltd. (HDB), a leading biology-focused preclinical Contract Research Organization (CRO), held An unveiling ceremony for the grand opening of company’s new state-of-the-art drug R&D service facility on Friday, 21st of October, 2016. |
|
• | |
|
|
HD Biosciences Co., Ltd. (HDB), a leading biology-focused preclinical Contract Research Organization (CRO), discloses today that, for the past three months, several project teams, business managers and a few dozens of scientists have received various awards from HDB’s partners and clients to recognize exceptional performance and valuable deliveries on collaboration. |
|
• | |
|
|
HD Biosciences Co., Ltd. (HDB), a leading biology-focused preclinical Contract Research Organization (CRO), announced today that the company will soon open a R&D service center in San Diego, California, USA. The projected open date is July, 2015. |
|
|
|
|
|